GxP Lifeline
"How Coronavirus, Brexit and Hurricanes Are Impacting the Global Supply Chain"
A reliable supply of medicinal product plays a critical role in protecting the world from threats when they need it most, such as infectious disease outbreaks and disaster situations. Man-made and natural disasters, political climates, and pandemic illnesses can all pose unique and life-threatening challenges to the world’s pharmaceutical global supply chains. Whether regional demand increases as a result of by disasters or global demand is increased by a pandemic, one thing is clear – the conditions that cause demand to rise also threaten the stability of our global supply chains and our ability to meet the demand. To avoid catastrophe, supply chains must diversify – the industry must be proactive and adopt a supply chain risk management model. Read the full article written by Coda Corp USA.
Gina Guido-Redden is a quality and regulatory professional with over 25 years of domestic and international industry experience. She is the co-founder and chief operations officer of Coda Corp USA, which provides consultancy services to pharmaceutical, biologics and medical device firms.
Guido-Redden’s history specializes in the areas of facility start up, regulatory compliance and remediation, quality system development, mentorship and training, quality system design, and implementation and management.
She is also a quality systems subject matter expert (SME), frequent seminar presenter, and content contributor to industry publications, including GAMP’s White Paper on Part 11, The Journal of Validation Technology, New Generation Pharmaceuticals, Computer Validation Digest, and MasterControl’s GxP Lifeline. Coda Corp USA is an enterprise partner of MasterControl.
